The Oral Anticoagulants Administration in Elderly Patients with Geriatric Syndromes: What's New?
Open Access
- 30 December 2020
- journal article
- research article
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 16 (6), 984-993
- https://doi.org/10.20996/1819-6446-2020-12-03
Abstract
The administration of oral anticoagulants in elderly patients with geriatric syndromes such as senile asthenia syndrome, falls and high risk of falls, dementia, polymorbidity, polypharmacy are discussed in the article. The evidence base for the anticoagulants taking in patients with atrial fibrillation aged ≥75, ≥80, ≥85 and ≥90 years, in patients with atrial fibrillation and various geriatric syndromes, as well as in elderly patients with venous thromboembolic complications and frailty syndrome is presented. Most studies indicate significant advantages of direct oral anticoagulants (dabigatran, rivaroxaban, apixaban, and edoxaban) over the vitamin K antagonist warfarin in elderly patients with geriatric syndromes. An updated version of the FORTA consensus document, which aims to optimize the prescription of medicines for the elderly, is also presented. Apixaban has a FORTA-A safety class and is the safest oral anticoagulant in elderly patients.Keywords
This publication has 54 references indexed in Scilit:
- Consensus Validation of the FORTA (Fit fOR The Aged) List: A Clinical Tool for Increasing the Appropriateness of Pharmacotherapy in the ElderlyDrugs & Aging, 2013
- Edoxaban versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2013
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous ThromboembolismThe New England Journal of Medicine, 2013
- Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studiesThrombosis Journal, 2013
- Apixaban versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2011
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationThe New England Journal of Medicine, 2011
- Dabigatran versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2009
- MULTIMORBIDITY AND POLYPHARMACY: HOW TO REDUCE THE HARMFUL DRUG LOAD AND YET ADD NEEDED DRUGS IN THE ELDERLY? PROPOSAL OF A NEW DRUG CLASSIFICATION: FIT FOR THE AGEDJournal of the American Geriatrics Society, 2009
- The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillationAge and Ageing, 2008
- Arzneimitteltherapie im Alter: Zu viel und zu wenig, was tun?Deutsche Medizinische Wochenschrift (1946), 2008